Guardant Health, Inc. · NASDAQ:GH

Talasaz AmirAli sold 260,000 Guardant Health, Inc. shares (Form 4)

Traded Jun 26 to Jun 29, 2026 · Filed Jun 30, 2026

From Jun 26 to Jun 29, 2026, Talasaz AmirAli (Director, Co-Chief Executive Officer) sold 260,000 Guardant Health, Inc. shares at an average US$151.20 for US$39.3M under a trading plan, leaving 1,881,336 shares. Filed Jun 30, 2026 (Form 4).

Sold
260,000 shares
Price
US$151.20 average (US$150.49 to US$153.00)
Value
US$39.3M
Holding after
1,881,336 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Co-Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 26, 2026Common StockOption exercise111,804US$4.181,998,308Indirect
Jun 26, 2026Common StockSale64,037US$150.491,934,271Indirect
Jun 26, 2026Common StockSale52,935US$151.161,881,336Indirect
Jun 29, 2026Common StockOption exercise143,028US$4.182,024,364Indirect
Jun 29, 2026Common StockSale25,812US$150.531,998,552Indirect
Jun 29, 2026Common StockSale70,513US$151.471,928,039Indirect
Jun 29, 2026Common StockSale46,663US$152.201,881,376Indirect
Jun 29, 2026Common StockSale40US$153.001,881,336Indirect

Source

View original at SEC

Related